LakeShore Biopharma Intangible Assets Over Time
| LSB Stock | 2.75 0.23 7.72% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out LakeShore Biopharma Performance and LakeShore Biopharma Correlation. LakeShore |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of LakeShore Biopharma. If investors know LakeShore will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about LakeShore Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.57) | Revenue Per Share 5.363 | Quarterly Revenue Growth 0.277 | Return On Assets (0.14) | Return On Equity (0.66) |
The market value of LakeShore Biopharma Co, is measured differently than its book value, which is the value of LakeShore that is recorded on the company's balance sheet. Investors also form their own opinion of LakeShore Biopharma's value that differs from its market value or its book value, called intrinsic value, which is LakeShore Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because LakeShore Biopharma's market value can be influenced by many factors that don't directly affect LakeShore Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between LakeShore Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if LakeShore Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, LakeShore Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Intangible Assets Analysis
Compare LakeShore Biopharma Co, and related stocks such as Air Lease, Fortress Transp Infra, and Avis Budget Group Intangible Assets Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AL | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| FTAI | 52 M | 52 M | 52 M | 52 M | 52 M | 44.1 M | 39 M | 40 M | 38.5 M | 27.7 M | 18.8 M | 98.7 M | 42 M | 50.6 M | 49.7 M |
| CAR | 49.5 M | 713 M | 731 M | 923 M | 886 M | 917 M | 870 M | 850 M | 825 M | 798 M | 774 M | 724 M | 666 M | 670 M | 636.5 M |
| PK | 52 M | 52 M | 52 M | 52 M | 52 M | 52 M | 44 M | 41 M | 27 M | 46 M | 45 M | 44 M | 43 M | 42 M | 34.9 M |
| VSTS | 276.9 M | 276.9 M | 276.9 M | 276.9 M | 276.9 M | 276.9 M | 276.9 M | 276.9 M | 276.9 M | 276.9 M | 276.9 M | 264.3 M | 238.6 M | 212.8 M | 198.5 M |
| LTH | 168.2 M | 168.2 M | 168.2 M | 168.2 M | 168.2 M | 168.2 M | 168.2 M | 168.2 M | 168.2 M | 168.2 M | 164.4 M | 174.2 M | 173.4 M | 172.1 M | 187.5 M |
| WSC | 157.7 M | 157.7 M | 157.7 M | 157.7 M | 157.7 M | 157.7 M | 125 M | 126.3 M | 131.8 M | 126.6 M | 495.9 M | 460.7 M | 419.1 M | 419.7 M | 301 M |
| UHAL | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
LakeShore Biopharma Co, and related stocks such as Air Lease, Fortress Transp Infra, and Avis Budget Group Intangible Assets description
Non-physical assets possessed by a company, such as patents, trademarks, and copyrights, which provide long-term value.My Equities
My Current Equities and Potential Positions
| LakeShore Biopharma Co, | LSB |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Location | China |
| Exchange | NASDAQ Exchange |
null 2.75
Check out LakeShore Biopharma Performance and LakeShore Biopharma Correlation. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
LakeShore Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.